Newly approved myeloma treatment found highly effective in first real-world patient population
In a first test of more typical patients with multiple myeloma, a newly FDA-approved drug proved nearly as effective as in clinical trial
Adding daratumumab to standard treatment for Multiple Myeloma increases progression-free survival
CANCER DIGEST – Feb. 2, 2024 – Adding the drug daratumumab (Darzalex®) to standard treatment substantially increased survival in patients...
